Evidence map›Paper›PMID 41858727›Full record

ArticleBioactive materials2026

Reprogrammable 4D tissue engineering hydrogel scaffold via reversible ion printing.

Aixiang Ding, Fang Tang, Sriramya Ayyagari, Eben Alsberg

Abstract read
In one paragraph

Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Smart Bioinks for 4D Bioprinting: Requirements, Design, and Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Aixiang DingRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, IL, 60612, USA.
Fang TangDepartment of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, 60611, USA.
Sriramya AyyagariRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, IL, 60612, USA.
Eben AlsbergRichard and Loan Hill Department of Biomedical Engineering, University of Illinois at Chicago, IL, 60612, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Shape-morphable hydrogel scaffolds recapitulating morphological dynamism of native tissues represent an elegant tool for tissue engineering (TE) applications. Current morphable hydrogels are predominantly based on multimaterial structures, which involve complicated and time-consuming fabrication protocols, and are often limited to unidirectional deformation. This work reports on the development of a transformable hydrogel system using a fast, simple, and robust fabrication approach for manipulating the shapes of soft tissues at defined maturation states. Simply by using an ion-transfer printing (ITP) technology, a tunable ion crosslinking density gradient across the hydrogel thickness has been incorporated, which enables preprogrammable deformations upon further swelling in cell culture media. Combining with a surface patterning technology, cell-laden constructs (bioconstructs) capable of morphing in multiple directions are deformed into sophisticated configurations. Not only can the deformed bioconstructs recover their original shapes by chemical treatment, but at user-defined times they can also be incorporated with new, different spatially controlled gradient crosslinking via the ITP process, conferring 3D bioconstruct shape reprogrammability. In this manner, unique "3D-to-3D" shape conversions have been realized. Finally, effective shape manipulation in engineered cartilage-like tissue constructs has been demonstrated. These morphable scaffolds may advance 4D TE by enabling sophisticated spatiotemporal control over construct shape evolution.

Indexed as

4D printingBiomimicryCrosslinking gradientShape morphingTissue development

Identifiers

PMID41858727
PMCPMC12996232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.